Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-08 Purchase |
2024-04-10 7:17 pm |
Annexon Inc. | ANNX | Carson William H. Director |
3,200 | $6.066 | $19,411 | 3,200 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:31 pm |
Annexon Inc. | ANNX | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER |
2,593 | $5.53 | $14,339 | 242,058 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:31 pm |
Annexon Inc. | ANNX | Yednock Ted EVP & CHIEF INNOVATION OFFICER |
2,604 | $5.51 | $14,348 | 253,471 (Indirect Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:31 pm |
Annexon Inc. | ANNX | Overdorf Michael EVP & CHIEF BUSINESS OFFICER |
1,951 | $5.48 | $10,691 | 245,641 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 7:59 pm |
Annexon Inc. | ANNX | Overdorf Michael EVP & CHIEF BUSINESS OFFICER |
1,349 | $5.53 | $7,460 | 48,592 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 7:56 pm |
Annexon Inc. | ANNX | Love Douglas PRESIDENT AND CEO |
5,782 | $5.54 | $32,032 | 196,121 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 7:54 pm |
Annexon Inc. | ANNX | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER |
1,809 | $5.54 | $10,022 | 45,651 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 7:52 pm |
Annexon Inc. | ANNX | Yednock Ted EVP & CHIEF INNOVATION OFFICER |
1,810 | $5.54 | $10,027 | 57,075 (Indirect Direct) |
View |
| 2023-07-11 Sale(A) |
2024-01-23 5:00 pm |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
22,057 | $4.4893 | $99,021 | 58,885 (Indirect Direct) |
View |
| 2023-07-11 Sale |
2024-01-23 4:58 pm |
Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer |
978 | $3.8361 | $3,752 | 45,802 (Direct) |
View |
| 2023-07-11 Sale |
2024-01-23 4:57 pm |
Annexon Inc. | ANNX | Lew Jennifer EVP & Chief Financial Officer |
1,057 | $3.8361 | $4,055 | 47,460 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-29 4:12 pm |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
21,000 | $4.5222 | $94,966 | 36,000 (Direct) |
View |
| 2023-12-26 Purchase |
2023-12-28 4:30 pm |
Annexon Inc. | ANNX | Satter Muneer A Director 10% Owner |
350,000 | $2.88 | $1,008,000 | 7,406,024 (Indirect) |
View |
| 2023-05-25 Purchase |
2023-05-30 9:54 pm |
Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. Bain Capital Life Sciences Partners LP BCIP Life Sciences Associates LP 10% Owner |
300,000 | $2.1324 | $639,720 | 5,701,926 (Indirect) |
View |
| 2023-02-15 Sale |
2023-02-17 5:12 pm |
Annexon Inc. | ANNX | Love Douglas President & CEO |
6,571 | $5.8688 | $38,564 | 197,646 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 7:00 pm |
Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer |
1,645 | $6.3029 | $10,368 | 27,805 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 6:59 pm |
Annexon Inc. | ANNX | Lew Jennifer EVP & Chief Financial Officer |
1,908 | $6.3077 | $12,035 | 29,542 (Direct) |
View |
| 2023-02-10 Purchase |
2023-02-14 4:31 pm |
Annexon Inc. | ANNX | Satter Muneer A Director 10% Owner |
2,647,058 | $6.8 | $17,999,994 | 7,056,024 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-16 Option Award |
2024-02-21 4:32 pm |
N/A 2034-02-16 |
Annexon Inc. | ANNX | Love Douglas PRESIDENT AND CEO |
656,200 | $0 | 656,200 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:32 pm |
N/A 2034-02-16 |
Annexon Inc. | ANNX | Dananberg Jamie CHIEF MEDICAL OFFICER |
199,000 | $0 | 199,000 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:32 pm |
N/A 2034-02-16 |
Annexon Inc. | ANNX | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER |
199,000 | $0 | 249,329 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:31 pm |
N/A 2034-02-16 |
Annexon Inc. | ANNX | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER |
199,000 | $0 | 242,058 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:31 pm |
N/A 2034-02-16 |
Annexon Inc. | ANNX | Yednock Ted EVP & CHIEF INNOVATION OFFICER |
199,000 | $0 | 253,471 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:31 pm |
N/A 2034-02-16 |
Annexon Inc. | ANNX | Overdorf Michael EVP & CHIEF BUSINESS OFFICER |
199,000 | $0 | 245,641 (Direct) |
View |
| 2023-12-27 Exercise(A) |
2024-01-23 5:00 pm |
N/A N/A |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
10,385 | $1.8501 | 58,885 (Direct) |
View |
| 2023-12-27 Exercise(A) |
2024-01-23 5:00 pm |
N/A N/A |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
10,615 | $1.4096 | 58,885 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:12 pm |
N/A N/A |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
10,385 | $1.8501 | 36,000 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:12 pm |
N/A N/A |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
10,615 | $1.4096 | 36,000 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:12 pm |
N/A 2025-01-22 |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
21,000 | $0 | 36,000 (Direct) |
View |
| 2023-08-01 Option Award |
2023-08-02 5:07 pm |
N/A 2033-08-01 |
Annexon Inc. | ANNX | Dananberg Jamie Chief Medical Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 5:52 pm |
N/A 2033-06-08 |
Annexon Inc. | ANNX | Satter Muneer A Director 10% Owner |
24,000 | $0 | 24,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:50 pm |
N/A 2033-06-08 |
Annexon Inc. | ANNX | WIGGANS THOMAS G Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:49 pm |
N/A 2033-06-08 |
Annexon Inc. | ANNX | Choi Jung Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:48 pm |
N/A 2033-06-08 |
Annexon Inc. | ANNX | Cockroft Bettina M. Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:45 pm |
N/A 2033-06-08 |
Annexon Inc. | ANNX | Waddill William D. Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:44 pm |
N/A 2033-06-08 |
Annexon Inc. | ANNX | Carson William H. Director |
24,000 | $0 | 24,000 (Direct) |
View |
Ownership |
2023-05-30 9:55 pm |
N/A N/A |
Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. Bain Capital Life Sciences Partners LP BCIP Life Sciences Associates LP 10% Owner |
0 | $0 | 8,916,344 (Indirect) |
View |
Ownership |
2023-03-27 5:44 pm |
N/A N/A |
Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer |
0 | $0 | 744,947 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:28 pm |
N/A 2033-02-16 |
Annexon Inc. | ANNX | Love Douglas President & CEO |
345,000 | $0 | 345,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:27 pm |
N/A 2033-02-16 |
Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer |
96,025 | $0 | 123,830 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:26 pm |
N/A 2033-02-16 |
Annexon Inc. | ANNX | Lew Jennifer EVP & Chief Financial Officer |
96,025 | $0 | 125,567 (Direct) |
View |
| 2023-01-15 Option Award |
2023-01-18 7:43 pm |
N/A 2033-01-15 |
Annexon Inc. | ANNX | ARTIS DEAN RICHARD EVP & Chief Scientific Officer |
210,000 | $0 | 210,000 (Direct) |
View |
Ownership |
2023-01-12 4:40 pm |
N/A N/A |
Annexon Inc. | ANNX | ARTIS DEAN RICHARD EVP & Chief Scientific Officer |
0 | $0 | 147,295 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-13 7:49 pm |
N/A 2032-07-11 |
Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer |
84,375 | $0 | 96,875 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-13 7:46 pm |
N/A 2032-07-11 |
Annexon Inc. | ANNX | Love Douglas President & CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-13 7:40 pm |
N/A 2032-07-11 |
Annexon Inc. | ANNX | Mattheakis Larry EVP & Chief Scientific Officer |
42,188 | $0 | 54,688 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-13 7:37 pm |
N/A 2032-07-11 |
Annexon Inc. | ANNX | Mattheakis Larry EVP & Chief Scientific Officer |
42,188 | $0 | 54,688 (Direct) |
View |